<DOC>
	<DOCNO>NCT00808028</DOCNO>
	<brief_summary>The purpose study evaluate safety immunogenicity investigational meningococcal B rLP2086 vaccine adolescent age 11 18 year old .</brief_summary>
	<brief_title>A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Meningococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy male female subject age &gt; =11 &lt; =18 year time enrollment . Negative urine pregnancy test female subject . Parent/legal guardian subject supervision parent/legal guardian must able complete relevant study procedure study participation . History invasive meningococcal disease . A previous anaphylactic severe vaccineassociated adverse reaction . Any clinically significant chronic disease . A know suspected disease immune system receive immunosuppressive therapy , include systemic corticosteroid . Topical , inhale intraarticular corticosteroid allow . Participation another investigational study 1month ( 30day ) period study visit 1 conduct study .</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>